Nkarta (NKTX) Interest & Investment Income (2019 - 2026)
Nkarta's (NKTX) quarterly Interest & Investment Income came in at $2.8 million in Q1 2026, down 35.15% year-on-year from $4.4 million in Q1 2025, and down 13.9% quarter-over-quarter from $3.3 million in Q4 2025.
Nkarta (NKTX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Nkarta's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 35.15% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $14.0 million, a 31.75% decrease from a year earlier, with the FY2025 full-year figure at $15.5 million, down 19.79% from the prior year.
- Interest & Investment Income fell to $2.8 million in Q1 2026 per NKTX's latest filing, from $3.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.7 million in Q2 2024 and bottomed at $112000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $3.5 million (2023), against an average of $3.4 million.
- Across the five-year window, Interest & Investment Income surged 2993.75% in 2023 and tumbled 35.15% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $2.9 million in 2022, then rose by 19.58% to $3.5 million in 2023, then soared by 41.61% to $4.9 million in 2024, then tumbled by 32.65% to $3.3 million in 2025, then slipped by 13.9% to $2.8 million in 2026.
- Per Business Quant, the three latest NKTX Interest & Investment Income figures stand at $2.8 million (Q1 2026), $3.3 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Nkarta | 168.94 Mn | 168.94 Mn | - | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.85 Mn |
| Jun 30, 2025 | 3.97 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 4.89 Mn |
| Sep 30, 2024 | 5.45 Mn |
| Jun 30, 2024 | 5.72 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 3.62 Mn |
| Jun 30, 2023 | 3.57 Mn |
| Mar 31, 2023 | 3.47 Mn |
| Dec 31, 2022 | 2.89 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 686,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | -448,000.00 |
| Sep 30, 2021 | 81,000.00 |
| Jun 30, 2021 | 104,000.00 |